The Tuberculosis Behavioral and Social Science Research Forum Proceedings
|Return to Behavioral Proceedings Main Menu|
Section II. Presentations and Panel Discussions
Closing Remarks: Maintaining the Momentum on Development of a Tuberculosis Research Agenda
Nick DeLuca, M.A.
Team Leader, Education, Training, and Behavioral Studies Team, Communications, Education, and Behavioral Studies Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention
Day 2, Afternoon Session
Nick DeLuca, CDC DTBE’s Forum Team Co-Leader, delivered closing remarks. He acknowledged the Forum Steering Committee, local TB program staff, and CDC staff and contractors who helped plan and implement the Forum. Mr. DeLuca described the following next steps that CDC may take to maintain the momentum for developing the TB behavioral and social science research agenda:
- Behavioral science electronic mailing list and e-mail communications to generate more input on TB research needs from Forum participants and interested persons who could not attend;
- Database to store the literature reviews; and
- Report of the TB behavioral and social science literature review, guided by the themes identified in breakout group discussions.
Information gathered from Forum presentations, panel discussions, and breakout sessions reaffirmed the ongoing need for behavioral and social science research to inform improvements in the practice of TB prevention, control, and treatment. Solid research is needed to address important TB outcomes, such as patient adherence and provider practices, and social and cultural issues that influence all facets of the ongoing TB epidemic and responses to it. Several key points came out of this Forum:
- TB patients, providers, and researchers offer diverse and important perspectives on the challenges and potential solutions to be addressed by future TB behavioral and social science research and TB treatment and control programs;
- Multidisciplinary and multilevel approaches to improving TB control and treatment efforts should involve key stakeholders such as patients, providers, families, communities, health systems, and policy makers; and
- Innovative research and tailored interventions are needed to improve existing TB treatment and control efforts and to overcome the social, cultural, environmental and structural challenges faced by patients, providers, communities, and TB programs.
The perspectives compiled from Forum attendees and ongoing Forum-related activities will be essential components of the CDC DTBE’s forthcoming TB research agenda. The Forum Proceedings will be shared with stakeholders and interested parties. It is CDC’s hope that this document will be widely used by those working in TB prevention, control, and treatment.